File:Ampligen chemical structure.png

Hemispherx Ampligen® (Poly I: Poly C12U, rintatolimod) For Chronic Fatigue Syndrome Figure 1: Structural Formula of Poly I: Poly C12U

Source: Applicant’s proposed label (Module 1.14.1.3), submitted 9/13/12 from Hemispherx Biopharma presentation to FDA on Dec 20, 2012 (since removed from FDA website), also available on https://www.pharmamedtechbi.com/~/media/Supporting%20Documents/The%20Pink%20Sheet%20DAILY/2012/December/Ampligen_AC_FDA_briefing.pdf

Fair use - no commercial approval yet